Chapter 45 - PHARMACY AUDIT INTEGRITY AND TRANSPARENCY ACT.
- Section 4501 - Short title
- Section 4502 - Scope of act
- Section 4503 - Definitions
- Section 4504 - Regulations
- Section 4511 - Procedures for conducting pharmacy audits
- Section 4512 - Appeals process
- Section 4513 - Limitations
- Section 4514 - Regulations
- Section 4521 - PBM and auditing entity registration
- Section 4525 - Contract provisions
- Section 4526 - Patient steering
- Section 4527 - Clawbacks prohibited
- Section 4528 - Network adequacy
- Section 4531 - Multiple source generic list and reimbursement
- Section 4532 - Availability of multiple source generic list
- Section 4533 - Multiple source drug pricing appeals process
- Section 4533.1 - PBM transparency report required.
- Section 4534 - [Repealed]
- Section 4534.1 - PSAO reporting requirements
- Section 4535 - Applicability
- Section 4541 - Definitions
- Section 4542 - Program payment
- Section 4543 - Generic drugs
- Section 4551 - Scope of enforcement authority
- Section 4555 - Definitions
- Section 4556 - Administration of injectable medications, biologicals and immunizations
- Section 4557 - Clinical laboratory certificate
- Section 4558 - Report on pharmacy-administered vaccines
- Section 4561 - Repeals
- Section 4562 - Effective date